Atlas Trials

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Clinical trial NCT03556956 · COMPLETED

Trial details

NCT number
NCT03556956
Sponsor
AB Science
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2015-07-01
Primary completion
2020-12-01
Enrollment
219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.